Chief Technical Operations Officer · Q32 Bio Inc. (QTTB)

Tim Kelly

FY2018 is the first fiscal year CompBrief holds for Tim Kelly as a named executive officer of Q32 Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$2,185,396

Salary $353,600Stock awards $0

2nd of 3 named executive officers at Q32 Bio by FY2018 total.

3 named officers on file for Q32 Bio, FY2018

Tim Kelly’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Q32 Bio’s whole pay program stands against its peers

  • Q32 Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on QTTB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2019 (DEF 14A).

Free

Get Tim Kelly’s full pay file as a PDF — free

More than this page: up to 10 years of Tim’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Tim Kelly compensation by year

Q32 Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Q32 Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$353,600
Stock awards$0
Option awards$1,704,058
Non-equity incentive$123,760
Pension and deferred compensation$0
All other$3,978
Total$2,185,396

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Q32 Bio Inc. DEF 14A filed April 25, 2019, accession 0001193125-19-119853, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Q32 Bio Inc. filed document, accession 0001193125-19-119853. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option36,621—$6.63
Option66,000—$24.28
Option22,964—$2.89
Option77,190—$16.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Q32 Bio Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Q32 Bio’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Arthur TzianabosPresident and Chief Executive Officer$4,313,115
Tim Kelly · this pageChief Technical Operations Officer$2,185,396
Albert SeymourChief Scientific Officer$2,123,757

The full Q32 Bio compensation record

free company brief

This page is one person within Q32 Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Q32 Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Tim Kelly's compensation dossier · One-time report. No refunds.